Related references
Note: Only part of the references are listed.Recombinant Human Matrix Metalloproteinase-2 Impairs Cardiovascular β-Adrenergic Responses
Karina C. Ferraz et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension
Vanessa Fontana et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Circulating matrix metalloproteinases and their inhibitors in hypertension
Vanessa Fontana et al.
CLINICA CHIMICA ACTA (2012)
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension
Carla S. Ceron et al.
MATRIX BIOLOGY (2012)
Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
Michele M. Castro et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2012)
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats
Paulo W. Pires et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Doxycycline Dose-dependently Inhibits MMP-2-Mediated Vascular Changes in 2K1C Hypertension
Danielle A. Guimaraes et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target
Vanessa Fontana et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension
S. B. A. Cau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension
Michele M. Castro et al.
PHARMACOLOGICAL RESEARCH (2011)
Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature
Michael O. Griffin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Matrix metalloproteinases cleave the β2-adrenergic receptor in spontaneously hypertensive rats
Stephen F. Rodrigues et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension
C. S. Ceron et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase
Nungavaram S. Ramamurthy et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Role of NF-κB in Flow-Induced Vascular Remodeling
Yves Castier et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
Michele M. Castro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
Michele A. Castro et al.
ATHEROSCLEROSIS (2008)
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
Marcio L. L. Martinez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Role of matrix metalloproteinases in early hypertensive vascular remodeling
Martin Flamant et al.
HYPERTENSION (2007)
Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats
Stephanie W. Watts et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition
C Bouvet et al.
HYPERTENSION (2005)
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
ACT Palei et al.
ANGIOLOGY (2005)
Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug
HM Lee et al.
JOURNAL OF PERIODONTOLOGY (2004)
Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway
L Hao et al.
CIRCULATION RESEARCH (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Prognostic significance of small-artery structure in hypertension
D Rizzoni et al.
CIRCULATION (2003)
Share Paper
